Shorea Lbg - Net Worth and Insider Trading
Shorea Lbg Net Worth
The estimated net worth of Shorea Lbg is at least $3.1 Billion dollars as of 2024-12-04. Shorea Lbg is the 2201 Interest of corporation controlled by you of Luye Pharma Group Ltd and owns about 1,259,196,703 shares of Luye Pharma Group Ltd (HKSE:02186) stock worth over $3.1 Billion. Details can be seen in Shorea Lbg's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Shorea Lbg has not made any transactions after 2024-04-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Shorea Lbg
Shorea Lbg Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Shorea Lbg owns 1 companies in total, including Luye Pharma Group Ltd (HKSE:02186) .
Click here to see the complete history of Shorea Lbg’s form 4 insider trades.
Insider Ownership Summary of Shorea Lbg
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
HKSE:02186 | Luye Pharma Group Ltd | 2024-04-10 | 2201 Interest of corporation controlled by you |
Shorea Lbg Latest Holdings Summary
Shorea Lbg currently owns a total of 1 stock. Shorea Lbg owns 1,259,196,703 shares of Luye Pharma Group Ltd (HKSE:02186) as of April 10, 2024, with a value of $3.1 Billion.
Latest Holdings of Shorea Lbg
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
HKSE:02186 | Luye Pharma Group Ltd | 2024-04-10 | 1,259,196,703 | 2.50 | 3,147,991,758 |
Holding Weightings of Shorea Lbg
Shorea Lbg Form 4 Trading Tracker
According to the SEC Form 4 filings, Shorea Lbg has made a total of 12 transactions in Luye Pharma Group Ltd (HKSE:02186) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Luye Pharma Group Ltd is the sale of 0 shares on April 10, 2024, which brought Shorea Lbg around $0.
Insider Trading History of Shorea Lbg
- 1
Shorea Lbg Trading Performance
GuruFocus tracks the stock performance after each of Shorea Lbg's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Shorea Lbg is -16.72%. GuruFocus also compares Shorea Lbg's trading performance to market benchmark return within the same time period. The performance of stocks bought by Shorea Lbg within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Shorea Lbg's insider trading performs compared to the benchmark.
Performance of Shorea Lbg
Shorea Lbg Ownership Network
Ownership Network List of Shorea Lbg
Ownership Network Relation of Shorea Lbg
Shorea Lbg Owned Company Details
What does Luye Pharma Group Ltd do?
Who are the key executives at Luye Pharma Group Ltd?
Shorea Lbg is the 2201 Interest of corporation controlled by you of Luye Pharma Group Ltd. Other key executives at Luye Pharma Group Ltd include 2201 Interest of corporation controlled by you UBS Group AG , 2301 Trustee Liu Dianbo , and 2101 Beneficial owner LuYe Pharmaceutical Investment Co., Ltd. .
Luye Pharma Group Ltd (HKSE:02186) Insider Trades Summary
Over the past 18 months, Shorea Lbg made 6 insider transaction in Luye Pharma Group Ltd (HKSE:02186) with a net purchase of 2,000,000. Other recent insider transactions involving Luye Pharma Group Ltd (HKSE:02186) include a net sale of 73,433,500 shares made by UBS Group AG , a net purchase of 2,000,000 shares made by Luye Pharma Holdings Ltd. , and a net purchase of 2,000,000 shares made by LuYe Pharmaceutical Investment Co., Ltd. .
In summary, during the past 3 months, insiders sold 0 shares of Luye Pharma Group Ltd (HKSE:02186) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 77,003,000 shares of Luye Pharma Group Ltd (HKSE:02186) were sold and 26,200,500 shares were bought by its insiders, resulting in a net sale of 50,802,500 shares.
Luye Pharma Group Ltd (HKSE:02186)'s detailed insider trading history can be found in Insider Trading Tracker table.
Luye Pharma Group Ltd Insider Transactions
Shorea Lbg Mailing Address
Above is the net worth, insider trading, and ownership report for Shorea Lbg. Currently GuruFocus does not have mailing address information for Shorea Lbg.